baber/WOPTO huggingface dataset:
Patent NZ-325390-A (NZ)
Title: Extruded plastics sheet material having voids therein
Inventor: MOEDER CLAUDIO
IPC: B29C47/06
Filed: 1997-01-09
Abstract: A rigid or semi-rigid plastics sheet material comprises a pair of opposed faces (20, 22) between which run elongate voids defined by interconnections (24, 25) between the two opposite faces, the cross-sectional shape of at least some of the voids being a polygon with more than four sides, preferably a repeating pattern of regular hexagons or octagons joined in a line at adjacent sides or apices and including triangular secondary voids therebetween. Advantages include higher strength, lighter weight and faster cooling during the extrusion process.
Patent NZ-332834-A (NZ)
Title: Glycosaminoglycan-related carbohydrate derivatives ( 5 saccharide groups ) having 4 to 6 sulphate groups
Inventor: VAN BOECKEL CONSTANT ADRIAAN A
IPC: A61K31/7028
Filed: 1998-11-17
Abstract: he application relates to carbohydrate derivatives of the formula I,  where R1 is alkoxy, R2, R3 and R4 are each alkoxy or OSO3-, which are useful for treating or preventing thrombosis and for inhibiting smooth muscle cell proliferation.
Patent NZ-334412-A (NZ)
Title: Filter element
Inventor: FLEISCHHACKER GERHARD
IPC: E03F5/06
Filed: 1997-09-02
Abstract: A filter element (1) for liquid permeable floor area fastening, a floor covering plate, a manhole cover, a sewage cavity or the like, with at least one pre-filtering layer (3) in the direction of the through-flow (2) and at least one following filter layer (4,4') is disclosed.  The free through-flow sections (a, b, b') of each layer (3, 4, 4') increase from layer to layer in the direction of the through-flow.  The filter also comprises a housing (5) which surrounds the filter layers (4,4') in a framelike manner and maintains them, wherein each filter layer (4,4') is formed from granular material and the grains are available in loose form or linked to each other by a weak binding agent.
Patent NZ-502000-A (NZ)
Title: Ostomy or incontinence pouch comprising a capsule containing an agent releaseable in response to environmental conditions
Inventor: STEER GRAHAM E
IPC: A01N25/34
Filed: 1999-12-22
Abstract: Capsule 80 is provided in pouch 10 and releases contents 84 (typically by bursting) in response to predetermined environmental conditions, such as water in the pouch or merely when pouch 80 is worn. The agent is typically a deodorizing agent.
Patent NZ-503640-A (NZ)
Title: Water-redispersible film-forming polymer powders prepared from ethylenically unsaturated monomers and containing naphthalenesulphonates
Inventor: BETT WILLIAM
IPC: C08L71/02
Filed: 1999-07-09
Abstract: This water-redispersible powder composition comprises a water-soluble film-forming polymer prepared from vinyl or acrylic ester monomers, and a naphthalenesulphonate of general formula (I). In formula (I); X and X' are OH or NH2; Y represents SO3-M+, wherein M is an alkaline metal; x = 0, x' = 0 and x + x' = 1; and y = 0, y' = 0 and y + y' = 1. The water-redispersed composition may be used as an additive to hydraulic binders, adhesives, cements, paper coatings and paints.
Patent NZ-504367-A (NZ)
Title: Vector for tissue-specific replication and gene expression
Inventor: CHANG YUNG-NIEN
IPC: A61K35/76
Filed: 1998-11-17
Abstract: An adenoviral expression vector comprises: a) A first coding sequence operably linked to a tissue specific transcriptional regulatory sequence. The gene product of the first coding sequence is essential for vector replication and the first coding sequence and the tissue-specific transcriptional regulatory sequence are not derived from the same gene, and b) At least one additional coding sequence encoding a heterologous gene product. The additional coding sequence is operably linked to the tissue specific transcriptional regulatory sequence and the first and at least one of the additional coding sequences are transcribed from a single tissue-specific transcriptional regulatory sequence. The vector may be in an isolated cell or virion. Also described is a method of modulating the replication of the vector replication in an isolated cell comprises introducing a nucleoside analogue that is phosphorylated by the gene product of the vector and a method to diagnose a cell for the ability to replicate the vector and to express the heterologous gene product.
Patent NZ-506611-A (NZ)
Title: Electricity generation for pedalled vehicles
Inventor: HICKS RICHARD BANFIELD
IPC: B62J3/00
Filed: 1999-02-02
Abstract: A generator (3) mounted within the tread portion (2) of a pedal (20) of a bicycle or the like is driven via pulleys (4) and (5) of unequal diameter and a gear box (7) so that the speed of rotation of the rotor of the generator is a multiple of the speed of relative rotation between the spindle (1) of the pedal and the tread portion (2) when the latter is held horizontal by a foot resting on it and the crank (not shown) from which the spindle (1) extends is rotated to propel the bicycle. The gearing up of the generator enables sufficient output voltage to illuminate an array (9) of LEDs and charge a capacitor (8) which will keep then illuminated while the pedal is temporarily stationary.
Patent NZ-511552-A (NZ)
Title: Sail apparatus
Inventor: HOUSLEY GARY DAVID
IPC: B63B35/79
Filed: 2001-05-07
Abstract: A mast step for a kayak sailing rig is provided. The mast step supports a mast relative to a deck of the kayak at a desired angle to facilitate an optimum sail shape. The step also has a convex below a surface which contacts the deck, allowing the mast to be rotated forward or aft in use, and in particular allowing the mast to be rotated from an upright position to a flat position against the deck of the kayak.
Patent NZ-515464-A (NZ)
Title: Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
Inventor: WYNN THOMAS A
IPC: C07K14/715
Filed: 2000-04-28
Abstract: Use of a protein in the manufacture of a medicament for treating tissue fibrosis in a mammalian subject, wherein said protein is an IL-13 antagonist or an IL-4 antagonist; wherein the IL-13 antagonist is selected from the group consisting of an IL-13 bc protein, a soluble form of IL- 13á1, an antibody to IL-13 or an IL-13 binding fragment thereof, an antibody to IL-13Rá1 or an IL-13Rá1 binding fragment thereof, IL-13R binding mutants of IL-4, a small molecule capable of inhibiting the interaction of IL-13 with IL-14Rbc or a small molecule capable of inhibiting the interaction of IL-13 with IL-13Rá1; and wherein the IL-4 antagonist is selected from the group consisting of a soluble form of IL-4R, an antibody to IL-4 or an IL-4 binding fragment thereof, an antibody to IL-4R of an IL-4 binding fragment thereof, and a small molecule capable of inhibiting the interaction of IL-4 with IL-4R.
Patent NZ-517464-A (NZ)
Title: Oligosaccharides derived from ribose-ribitol-phosphate, and vaccines containing them
Inventor: ROY RENE
IPC: C07H15/18
Filed: 2000-08-15
Abstract: A process for synthesising a mixture of oligosaccharides comprising the repeating units of formulae (phosphate-ribosa-ribitol)n A or (ribose-ribitol- phosphate)n B, wherein a polycondensation reaction is applied to disaccharide derivative 19 or 23, in the presence of a promoter that is an active derivative of sterically hindered acid, in a basic solvent with a spacer that participates in the reaction as an acceptor quenching the growth of the oligomeric chain.
Patent NZ-517527-A (NZ)
Title: Reduced fat whey protein concentrate and method of manufacture
Inventor: BOSWELL ROBERT PHILIP
IPC: A23C21/00
Filed: 2000-07-27
Abstract: This invention relates to reduced fat whey protein concentrate (WPC) and a method of producing such a WPC. The method of the invention involves concentrating the solids content of whey to produce an intermediate WPC, diluting the intermediate WPC with water to an ionic strength no greater than a preselected ionic strength, adjusting the pH of the diluted intermediate WPC to within the range 3.8 to 5.0, holding the pH at that level for a period to optimise formation of a floc, and removing the floc to leave a reduced fat WPC supernatant.
Patent NZ-520178-A (NZ)
Title: CO2 extraction of polygodial from Horopito
Inventor: CATCHPOLE OWEN
IPC: B01D11/00
Filed: 2002-07-15
Abstract: A method of extracting polygodial from Pseudowintera colorata (Horoptio plant) with a near critical fluid, then reducing the pressure of the near critical fluid obtained so as to recover the polygodial.
Patent NZ-520205-A (NZ)
Title: Base station handoff with mobile station measuring base signal energies and dynamically determining a threshold
Inventor: SOLIMAN SAMIR S
IPC: H04Q7/38
Filed: 1998-07-21
Abstract: The method relates to an alternative way of performing hand-off in a mobile communication system. The first step involves the mobile station (2) measuring the signal energies that it receives from all base stations (4A-4S) capable of communicating with the mobile station. Then, using more than one of the measured signal energies, a dynamic threshold value is computed. This dynamic threshold is used to compare with the signal level of a certain base station to determine if that base station can be selected for communication.
Patent NZ-520753-A (NZ)
Title: Pyridinylimidazoles
Inventor: GASTER LARAMIE MARY
IPC: A61P17/02
Filed: 2001-02-21
Abstract: Disclosed herein are pyridyl substituted imidazoles of formula (I) and pharmaceutically acceptable salts thereof, which are inhibitors of the transforming growth factor,("TGF")-b signaling pathway, in particular, the phosphorylation of smad2 or smad3 by the type I or activin-like kinase ("ALK")-5 receptor, methods for their preparation and their use in medicine, specifically in the treatment and prevention of a disease state mediated by this pathway, wherein R1, R2 and R3 represent various functional groups as defined in the specification, and one of X1 and X2 is N and the other is NR10.
Patent NZ-529512-A (NZ)
Title: Article removing container
Inventor: SENDA JUNJI
IPC: B65D77/30
Filed: 2001-05-14
Abstract: An article removing container (1) having such a structure that small articles such as candy and chocolate can be removed one by one comprises a container main body (3) having a storage part (14) capable of storing a plurality of articles of a specified shape and a cover body (9), and wherein an opening allowed to communicate with the storage part is formed in the container main body at a specified front position. The cover body is pivotally supported rotatably on the container main body so as to openably close the opening. The articles stored in the storage part are held on the rear side of the cover body, and an article removing means (15) remove the articles from the container main body according to the opening operation of the cover body.
Patent NZ-532176-A (NZ)
Title: Composition comprising cysteamine for improving lactation in dairy animals
Inventor: CHI FRANCIS
IPC: A23K1/16
Filed: 2002-09-18
Abstract: Disclosed is the use of a composition comprising cysteamine or a salt thereof, for improving or increasing lactation of non-human animals. Also disclosed is a method for improving lactation of non-human lactating animals, comprising: (a) producing a final feed by mixing a composition containing cysteamine and a stabilizer with a suitable basal feed for the animals, and (b) feeding the animals with the final feed.
Patent NZ-532571-A (NZ)
Title: Method and apparatus for weed control with hot foam of relatively low air content and relatively high "wet foam" content
Inventor: TINDALL DENNIS WALTER
Filed: 2002-09-27
Abstract: A method of controlling vegetation including the steps of: (a) preparing a relatively 'wet' foam having a temperature between 75 DEG C and 100 DEG C and consisting volumetrically of 60% to 75% aqueous solution of biodegradable foaming agent and 40% to 25% air, and (b) directing a stream of the foam against the surface to be treated. An apparatus for applying the foam to vegetation including a supply tank (1) for holding an aqueous "foamable" solution, a pump (4) for supplying the solution to a boiler (2) for heating, a blower (3) for supplying air, hoses (6 and 7) for carrying air and hot solution respectively to a lance (8) incorporating a mixing and expansion chamber.
Patent NZ-535484-A (NZ)
Title: Pharmaceutical compositions containing fospropofol (O-phosphonooxymethylpropofol) and methods of administering same
Inventor: WINGARD PEGGY
IPC: A61K31/66
Filed: 2003-04-08
Abstract: Fospropofol of formula I, or a pharmaceutically acceptable salt thereof, can be used in the manufacture of a medicament for inducing or maintaining general anaesthesia in a subject in need thereof, wherein the medicament is formulated for administration of at least one bolus injection and wherein said medicament is formulated to provide an amount of said compound of from greater than 15 to about 50 mg per kilogram of body weight. Parenteral bolus injections in an amount of from about 2 mg/kg to less than 15 mg/kg can produce a sedated state with preservation of consciousness in a subject in need thereof.
Patent NZ-537513-A (NZ)
Title: Post-evisceration process and apparatus
Inventor: TSANG HENG Y
IPC: A23B4/18
Filed: 2003-07-09
Abstract: A process and apparatus for removing or reducing the levels of pathogenic bacteria present on an eviscerated carcass. The process includes introducing the eviscerated carcass to a cleaning apparatus. The cleaning apparatus generally includes a housing structure having an entrance and an exit. Disposed within the housing structure are a rotating brush assembly and a spray assembly. The brushing assembly provides brushing and massaging actions to the surfaces of the carcass whereas the spraying assembly simultaneously directs a cleaning solution onto the surfaces of the carcass.
Patent NZ-538214-A (NZ)
Title: Catheter securement device
Inventor: BIERMAN STEVEN F
IPC: H01L21/027
Filed: 2003-08-15
Abstract: Disclosed is a medical line securement system comprising a medical article having at least one contact, at least one anchor pad including a lower adhesive surface configured to attach to an epidermal layer of a patient, and a retainer comprising a body member having a channel formed therethrough about a channel axis, the channel being configured to retain at least a portion of the medical article and having a longitudinal access opening disposed on an underside of the body member to allow at least ingress of the portion of the medical article into the channel, at least one abutment extending generally normal to the channel axis and configured to abut against the at least one contact so as to inhibit longitudinal movement of the medical article in at least one direction, and at least one support disposed on the underside of the retainer and to a side of the access opening opposite the channel axis, the support attached to the anchor pad so as to not block ingress of the portion of the medical article into the channel from a location below the at least one anchor pad.
Patent NZ-543549-A (NZ)
Title: A brush module for a grinding brush, with abrasive cloth in holder having projecting bead and two flaps either side of cloth
Inventor: HIMMER NINA
IPC: B24D13/06
Filed: 2004-05-18
Abstract: A brush module is disclosed for a rotating grinding brush, said brush module comprising: an elongate body part (7); at least one abrasive cloth (9) protruding from the body part (7); a plurality of bristles (8) extending from the body part (7) essentially in the same direction as the abrasive cloth (9). The body part (7) is provided with an undercut, longitudinally extending guide (13), and at an edge the abrasive cloth (9) is provided with a protruding bead that is complementary with the undercut groove (13) to the effect that the undercut guide (13) and the protruding bead constitute complementary mechanical interconnecting means for releasable mounting of the abrasive cloth (9) on the body part (7). The protruding bead is provided on a holder comprising two flaps between which an edge of the abrasive cloth (9) is securely clamped. Use of such abrasive cloth (9) in a rotating grinding brush with or without brush module is also disclosed.
Patent NZ-543855-A (NZ)
Title: Nucleic acid arrays for detecting multiple strains of a non-viral species
Inventor: MOUNTS WILLIAM MARTIN
IPC: C12Q1/68
Filed: 2004-06-03
Abstract: Nucleic acid arrays and methods of using the same for concurrent or discriminable detection of different strains of a non-viral species. In many embodiments, the nucleic acid arrays of the present invention include probes that are specific to different respective strains of a non-viral species. In many other embodiments, the nucleic acid arrays of the present invention include probes that are common to two or more different strains of the non-viral species. In one embodiment, the non-viral species is Staphylococcus aureus, and the different Staphylococcus aureus strains include COL, N315, MOO, EMRSA-16, MSSA-476, and 8325 strains. In another embodiment, a nucleic acid array of the present invention includes polynucleotide probes capable of hybridizing under stringent or nucleic acid array hybridization conditions to respective sequences selected from SEQ ID NOs: 1 to 7,852, or the complements thereof.
Patent NZ-547882-A (NZ)
Title: Method for preparing phthalocyanines
Inventor: GESSNER THOMAS
IPC: C07D487/22
Filed: 2004-12-30
Abstract: Disclosed is a method for preparing metal-free phthalocyanines having the formula (I) by reaction of an ortho-phthalodinitrile of formula (Ia) in an inert solvent having a boiling temperature of at least 120 °C (under normal pressure) in the presence of ammonia. In formulae I and Ia, the variable n can take the value of 1, 2, 3 or 4 and the radicals R denote a five- or six-membered saturated, nitrogen-containing heterocyclic ring that is optionally substituted by one or two C1-C8 alkyl groups, the heterocyclic ring being bonded to the benzene ring by a nitrogen atom in the ring; the heterocyclic ring may further contain one or two additional nitrogen atoms or an additional oxygen or sulphur atom. The method is characterised in that the reaction is performed in the presence of an alkaline metal hydroxide or alkaline metal carbonate.
Patent NZ-551930-A (NZ)
Title: A system and method for analysing risk associated with an investment portfolio
Inventor: SALTER GEOFFREY
IPC: G06Q40/00
Filed: 2005-06-01
Abstract: A system for analysing risk associated with an investment portfolio of an investor is disclosed. The system includes means for generating a user interface (1050) for display on a user terminal. The user interface (1050) shows a distribution of assets (1070) of each investment (1068) of the investment portfolio over one or more asset classes (1072) and shows the distribution of assets (1080) over the one or more asset classes (1072) of a benchmark risk category (1082) representing a risk tolerance level of the investor.
Patent NZ-554862-A (NZ)
Title: Improvements in or relating to packs for holding food items
Inventor: PHUNG QUANG
IPC: B65D75/52
Filed: 2005-11-01
Abstract: The disclosure relates to a pack for holding a food item or items comprising a bag (10) and a channel shaped holder (11) for the bag formed in card and comprising a pair of side walls (12,15) to which the sides of the bag are adhered by adhesive areas (40) and a base (14) hinged at first fold lines (21) to the side walls and having a plurality of spaced second fold lines (22) extending parallel to the first fold lines to allow the base to take up a generally convex or concave shape with the side walls of the holder spaced apart and holding the side walls of the bag apart.
Patent NZ-567428-A (NZ)
Title: Hydrolysis resistant organomodified disiloxane surfactants
Inventor: LEATHERMAN MARK D
IPC: C09K23/54
Filed: 2006-10-10
Abstract: Disclosed is a silicone of the formula R1R2R3SiOSiR4R5R6, where the substituents are as defined in the specification. Also disclosed are compositions comprising the silicone and water, for controlling wetting, spreading, foaming and detergency.
Patent NZ-569741-A (NZ)
Title: Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
Inventor: RENNER WOLFGANG
IPC: A61P37/00
Filed: 2006-12-14
Abstract: Disclosed is the use of a composition, wherein said composition comprises, essentially consists of, or consists of: (a) a particle, wherein said particle is a virus-like particle of an RNA bacteriophage; and (b) an immunostimulatory nucleic acid, wherein said immunostimulatory nucleic acid is an unmethylated CpG containing oligonucleotide; wherein said particle is packaged with said immunostimulatory nucleic acid, and wherein said composition is free of an allergen or an allergen extract, and wherein said composition is formulated for administration to said animal without administration of an allergen or allergen extract; in the manufacture of a medicament for treating hypersensitivity in an animal, wherein said hypersensitivity is an allergy, asthma or dermatitis.
Patent NZ-570036-A (NZ)
Title: Piperidinyl derivatives as modulators of chemokine recepteor activity
Inventor: CARTER PERCY H
IPC: A61K31/45
Filed: 2007-01-25
Abstract: Disclosed are piperidinyl derivatives represented by formula (Ib) or (Ib'), or stereoisomers or pharmaceutically acceptable salts thereof, wherein T is -C(O)- or -C(O)-NR8- and R2 is an optionally substituted alkyl. Also disclosed is the use the compounds of formula (Ib) or (Ib') in the preparation of a medicament for treating a disorder selected from osteoarthritis, aneurysm, fever, cardiovascular effects, Crohn's disease, congestive heart failure, autoimmune diseases, HIV-infection, HIV-associated dementia, psoriasis, idiopathic pulmonary fibrosis, transplant arteriosclerosis, hysically or chemically induced brain trauma, inflammatory bowel disease, alveolitis, colitis, systemic lupus erythematosus, nephrotoxic serum nephritis, glomerularnephritis, asthma, multiple sclerosis, artherosclerosis, rheumatoid arthritis, restinosis, organ transplantation, psoriatic arthritis, multiple myeloma, allergies, hepatocellular carcinoma, osteoporosis, renal fibrosis and cancer.
Patent NZ-571772-A (NZ)
Title: Orodispersible domperidone tablets
Inventor: CORDOLIANI JEAN-FRANCOIS
IPC: A61K31/454
Filed: 2007-03-14
Abstract: Disclosed is an orodispersible tablet comprised of, by weight: - a maximum of 15% of a low-dose, therapeutically active substance; - from 55% to 70% of mannitol of a particle size between 30 microns and 300 microns; - at least 2% of maltodextrin; - from 3.5% to 8% of croscarmellose sodium; - from 10% to 20% of microcrystalline cellulose; - from 0.5% to 1.5% of magnesium stearate; and - from 1% to 5% of flavouring(s) and sweetener(s)